Court modifies decision, excludes penalty levy, extends limitation period. Menthol claim denied for not meeting usage criteria.

The Court partially allowed the appeal, modifying the Tribunal's decision by excluding penalty levy and extending the limitation period application. The appellant's claim for excise duty exemption on Menthol was denied as it did not meet the criteria of being used as such or in formulations as required by the Drugs and Cosmetics Act. The Court emphasized the specific language of the notification and the necessity for substances to be used in formulations to qualify as bulk drugs under the exemption.

---

---

Issues:
Interpretation of Notification No. 31/88-C.E. dated 1-3-1988 regarding excise duty exemption for bulk drugs, Definition of "bulk drugs" under Drugs (Prices Control) Order, 1987, Applicability of the exemption to Menthol IP, Tribunal's decision on the eligibility of the appellant for the exemption, Precedents on similar notifications, Application of Section 11 for penalty levy, Clarifications on penalty imposition and limitation period.

Interpretation of Notification No. 31/88-C.E. dated 1-3-1988:
The appellant, a company manufacturing Menthol and Mentha Oil, operated under a license granted by drug control authorities. A notification exempting certain goods from excise duty was issued, specifying rates for different categories including bulk drugs. The notification defined "bulk drugs" as substances conforming to pharmacopoeial standards used as such or in formulations under the Drugs (Prices Control) Order, 1987.

Definition of "bulk drugs" under Drugs (Prices Control) Order, 1987:
The Drugs (Prices Control) Order, 1987 defines "bulk drug" as substances meeting pharmacopoeial standards used as such or in formulations. The appellant claimed Menthol as a bulk drug under the notification, availing the exemption until a show cause notice was issued challenging this classification.

Applicability of the exemption to Menthol IP:
The Collector imposed a differential excise duty demand and penalty on the appellant for allegedly wrongly availing the exemption. The Tribunal dismissed the appeal, ruling that Menthol cleared by the appellant did not qualify as a bulk drug under the Drugs and Cosmetics Act, thus not eligible for the exemption.

Tribunal's decision on the eligibility of the appellant for the exemption:
The Tribunal held that Menthol was not used as such or in formulations as required by the Act, leading to the denial of the exemption. The appellant argued citing precedents where end-use certification was deemed irrelevant for similar notifications, emphasizing the product's therapeutic properties.

Precedents on similar notifications:
The appellant referenced past judgments highlighting that end-use certification was not mandatory for exemption eligibility under certain notifications. However, the Court emphasized the specific language of the present notification and the need for substances to be used in formulations to qualify as bulk drugs.

Application of Section 11 for penalty levy:
Regarding penalty imposition under Section 11, differing views existed among authorities and courts. The Court found ambiguity in the law and issued clarifications, deciding that the penalty imposition was not justified in this case. The Tribunal's decision was modified to exclude penalty levy and extended limitation period application.

In conclusion, the Court partially allowed the appeal, modifying the Tribunal's decision on penalty imposition while maintaining other aspects of the order.

---